Reyataz
Product Images NDC 67296-1236

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 67296-1236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Reyataz 300mg (Doc20170511110456 001)

This is a label of Rx drug REYATAZ containing 4 capsules of dosage strength 300mg with Lot number 83239A 1 and expiry date 05/17. The usual adult dosage is available in the package insert provided. The drug is manufactured by Bristol-Myers Squibb Co located in Princeton NJ and distributed by Redpharm Drug Eden Prairie in Minnesota. The NDC number of the drug is 67296-1236-4, and it is advised to store at controlled room temperature between 20-25 C (88-77 F).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.